Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
Chikara Komiya(Tokyo Medical and Dental University), Yoshihiro Ogawa(Kyushu University)
Cited by 64
Related Papers
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
|PLoS ONE|2016|229
Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis
|Nature Communications|2014|196
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
|Scientific Reports|2018|174
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
|Scientific Reports|2018|86
A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition
|Scientific Reports|2018|57